Boston BioLife to Co-Present Translational Longevity Summit in 2026

Eleven years after its founding, Boston BioLife is expanding its mission to bridge science and clinical medicine by co-presenting the Translational Longevity Summit. The five-day event, scheduled for October 7-11, 2026, at Harvard’s Enterprise Research Campus in Boston, is presented by Boston BioLife and the Healthspan Action Coalition as part of Boston Longevity Week. It will convene leaders from science, medicine, technology, patient advocacy, policy, and investment to examine how promising discoveries can be responsibly evaluated, translated, and advanced toward meaningful clinical application.

Founder Joseph P. Krieger views the summit as a pivotal milestone for the organization, which he started in July 2015. “When I founded Boston BioLife, the goal was to help physicians understand emerging science and determine how it could responsibly contribute to better patient care,” Krieger said. “Eleven years later, this summit gives us the opportunity to expand that conversation across the entire translational ecosystem—from researchers and clinicians to patients, policymakers and investors.” His path to Boston BioLife began with an education in biochemistry and a career in medical-device technology and physician training, where he recognized that successful clinical adoption required deeper understanding of science, applications, limitations, regulatory considerations, and patient safety. That realization became the foundation of Boston BioLife.

The Translational Longevity Summit will explore aging, healthspan, regenerative medicine, personalized care, and the scientific and practical challenges of moving discoveries from research into responsible real-world use. It will emphasize cross-sector collaboration, with patient participation as a key component. “Translation does not happen within a single laboratory, company or medical practice,” Krieger added. “It requires researchers, clinicians, patients, regulators, advocates and responsible industry partners to ask better questions together. That is the community we are bringing together in Boston.” For a Massachusetts native who built his career near Boston’s medical and academic institutions, holding the summit at Harvard’s Enterprise Research Campus carries particular significance, bringing the original educational mission into an environment designed for research, innovation, and collaboration.